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PAR-1/MARK is required for the tau-induced neurode-PAR-1 for the Course
generation seen in these flies. To circumvent the embry-of Neurodegeneration onic lethality of fly par-1 mutants, clones of par-1 homo-
zygous mutant tissue were generated in developing fly
brains that simultaneously express mutant human tau.
In this key experiment, removal of PAR-1 function led
The large number of kinases that phosphorylate the to an 3-fold drop in levels of cell death relative to par-
microtubule binding protein tau has posed a challenge 1 neurons. This effect was accompanied by a dramatic
to understanding their individual roles in turning this reduction in tau phosphorylation on its two PAR-1/
protein into a killer of neurons. A study in this issue MARK-dependent sites S262 and S356. Conversely,
of Cell (Nishimura et al., 2004) uses an elegant fusion overexpression of PAR-1 enhanced tau toxicity and in-
of loss-of-function genetics and transgenic overex- creased phosphorylation on these two sites. Quantita-
pression to make the case that the PAR-1 kinase tive analysis of brain extracts indicated that a significant
stands at the head of a temporally ordered series of fraction (20%) of tau was phosphorylated at these two
tau phosphorylations. sites in the transgenic model, an amount that increased
to 80% upon PAR-1 overexpression, arguing that
PAR-1-phosphorylated tau is not a rare or transient pool.Imagine returning from work to find your house in disar-
Cementing these findings, mutation of the S262 andray, with lamps overturned, upholstery shredded, and
S356 sites largely abolished the neurotoxic effects ofitems strewn across the floor. With no signs of forcible
the overexpressed mutant tau in the Drosophila model.entry, you conclude that your beloved household pets
Intriguingly, overexpression of PAR-1 alone, in theare somehow responsible for the mess, but which ones?
absence of pathogenic human tau overexpression, alsoA similar conundrum has long confronted those inter-
caused eye degeneration in transgenic flies. This degen-ested in the microtubule binding protein tau, which is
eration was dependent upon a functional PAR-1 kinaseimplicated in neurodegenerative diseases including
domain, confirming that kinase activity and not overex-frontotemporal dementia and Alzheimer’s disease (Man-
pression per se was responsible and implying that physi-delkow and Mandelkow, 1998; Lee et al., 2001). In these
ological levels of PAR-1 must be reasonably tightly regu-“tauopathies,” tau is hyperphosphorylated in dying neu-
lated to prevent excess phosphorylation of tau androns, causing it to detach from microtubules and aggre-
perhaps other targets. Because the promoters used forgate into filamentous structures and larger inclusions
these transgenic studies are expressed in neuronal pre-called tangles, wreaking havoc on brain tissues. How-
cursors or newly born neurons just beginning to differen-ever, tau is phosphorylated on numerous residues and
tiate, a valid concern is that the resulting phenotypesseveral kinases are involved, leading to much debate
reflect developmental perturbations rather than neuro-
about which ones contribute most to tangle formation.
degeneration of mature neurons. To address this issue,
In this issue of Cell, Nishimura and coworkers (2004)
Nishimura and coworkers used a heat-shock promoter
show that one of the chief culprits in tau-related neuro- to induce PAR-1 expression at later stages, including
degeneration is the PAR-1/MARK kinase. young adult flies, and confirmed that such treatments
PAR-1 is a serine/threonine kinase first discovered in cause neurodegeneration of photoreceptors that had
C. elegans, where it regulates cell polarity and asymmet- been allowed to develop normally.
ric cell division (Guo and Kemphues, 1995). Drosophila So what about the other kinases that also phosphory-
PAR-1 and its mammalian ortholog MARK are likewise late tau? When Nishimura and colleagues examined the
needed for cellular processes involving microtubule or- phosphorylation status of their S262/S356 tau mutant,
ganization and cytoskeletal dynamics. MARK phosphor- they made a surprising discovery—phosphorylation on
ylates microtubule binding proteins including tau, lead- several other sites was markedly reduced, including
ing to microtubule disruption (Drewes et al., 1997; sites recognized by Cdk5 and GSK-3. This effect was
Jenkins and Johnson, 2000). However PAR-1/MARK is verified in par-1 loss-of-function mutant clones, arguing
only one of a long list of tau kinases identified through that tau phosphorylation by PAR-1 acts as a trigger
biochemical studies. Others include GSK-3, MAP ki- for subsequent multistep phosphorylations by other tau
nase, Cdk2 and 5, PKA, CaMKII, and several protein kinases. Consistent with this notion, elevation of either
phosphatase subunits, with GSK-3 and Cdk5 receiving Cdk5 or GSK-3 activity modestly increased phos-
much attention in terms of tau hyperphosphorylation phorylation at the appropriate sites, and even greater
(Lucas et al., 2001; Noble et al., 2003). Because these increases were achieved upon PAR-1 coexpression. It
studies generally relied upon kinase overexpression in should be noted that other phosphorylation sites on tau
cell culture or transgenic animals, it is critical to evaluate were unaffected by the S262/S356 mutations or by
their physiological relevance using loss-of-function ap- PAR-1 overexpression and that elevated Cdk5 and GSK-
proaches. 3 activity did not correlate well with tau toxicity in
The new study by Nishimura and colleagues is an certain transgenic combinations. Thus PAR-1-indepen-
important step in this direction. Using transgenic Dro- dent pathways also impinge upon tau phosphorylation
sophila that overexpress mutant forms of tau associated and function. Moreover, coexpression of tau and PAR-1
did not produce obvious neurofibrillary tangle-like pa-with human frontotemporal dementia, they asked whether
Cell
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Figure 1. Alternative Models for PAR-1 Function in Multistep Tau Phosphorylation
Tau associates with microtubules through its microtubule binding motifs (white stripes) and is phosphorylated by PAR-1 at two sites (S262
and S356 in human tau). PAR-1 phosphorylation might enable subsequent phosphorylation of tau by GSK-3 and Cdk5 by dislodging tau
from microtubules, thereby allowing these kinases to gain access to tau. Alternatively, PAR-1 phosphorylation might create specific docking
sites on tau for these kinases or induce conformational changes in tau that permit it to be recognized as a substrate by these kinases.
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The emerging picture is therefore one in which PAR-1 Molecular Genetics Section
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by Cdk5, GSK-3, and perhaps additional kinases.
Many questions remain about how tau hyperphos- Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.-M., and Mandel-
kow, E. (1997). Cell 89, 297–308.phorylation contributes to tangle formation and neuro-
degeneration and the mechanistic role of PAR-1 in this Guo, S., and Kemphues, K.J. (1995). Cell 81, 611–620.
process. Most investigators believe that tau phosphory- Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown,
lation weakens its affinity for microtubules and causes C.A., Massachi, S., and Geschwind, D.H. (2002). Neuron 34, 509–519.
it to detach, destabilizing microtubules and disrupting
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onal outgrowth and vesicle transport. PAR-1 phosphory-
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making it more accessible to other tau kinases, or it
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changes that allow these kinases to interact with tau
Mandelkow, E.-M., and Mandelkow, E. (1998). Trends Cell Biol. 8,(see Figure 1). It will also be important to learn how
425–427.PAR-1 itself is regulated. Indeed a recent study by Timm
Nishimura, I., Yang, Y., and Lu, B. (2004). Cell 116, this issue,and colleagues (2003) has identified MARKK, a kinase
671–682.of the Ste20 family, as a key activator of PAR-1/MARK.
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PAR-1/MARK and its upstream kinase MARKK indicate,
the stage is now set for unraveling the complex molecu-
lar events behind tau aggregation and altered microtu-
bule dynamics in human neurodegenerative disease.
